DLX6 and neoplasm: LncRNA DLX6-AS1 is overexpressed in GC and DLX6-AS1 knockdown inhibits tumor growth and aerobic glycolysis by targeting miR-4290 and 3-phosphoinositide-dependent protein kinase 1 (PDK1) (Qian et al., 2021).